Amynas

medical devices

About

Founded in 2019 in Antwerp, Belgium, Amynas' mission is to reduce implant-related infections - leading to reduced hospital re-admission rates for post-surgical complications. Its lead candidate product is a fully bioresorbable envelope made of millions of drug-coated immunomodulatory electrospun nanofibers specifically designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate - all while avoiding conventional antibiotics confronted with rising resistance rates. To conduct the high-level research needed to develop this new technology, Amynas is teaming up with several academic and private partners. Surrounded by the best and driven by an unmet medical need, Amynas aims to truly make a difference for patients with implantable devices.

Technologies

Google Cloud Hosting Wix Mobile Friendly Varnish Remote Circle

Keywords

medical equipment manufacturing bioengineering biofilm-resistant biomaterials healthy tissue growth drug delivery tissue regeneration medical devices anti-inflammatory nanofiber envelope biofilm-resistant materials bioinspired implant coating biofilm prevention research and development in the physical engineering and life sciences cell attachment 2-aminoimidazole molecules b2b antimicrobial resistance drug-coated nanofibers pro-healing scaffold biodegradable materials biotechnology regenerative medicine nanofibers electrospun nanofibers endogenous healing promotion immunomodulatory therapy bioactive nanofibers infection reduction biofilm disruption

Location

Antwerp, Flanders, Belgium

Related Companies

Companies in the same industry